J. Freeman, FURTHER OBSERVATIONS ON THE TREATMENT OF HAY FEVER BY HYPODERMIC INOCULATIONS OF POLLEN VACCINE., The Lancet, vol.178, issue.4594, pp.814-817, 1911.
DOI : 10.1016/S0140-6736(01)40417-X

J. Ring and J. Gutermuth, 100???years of hyposensitization: history of allergen-specific immunotherapy (ASIT), Allergy, vol.180, issue.Suppl 2, pp.713-724, 2011.
DOI : 10.1111/j.1398-9995.2010.02541.x

H. Fujita, M. Soyka, M. Akdis, and C. Akdis, Mechanisms of allergen-specific immunotherapy, Clinical and Translational Allergy, vol.2, issue.1, 2012.
DOI : 10.1186/2045-7022-2-2

E. Valovirta, S. Myrseth, and S. Palkonen, The voice of the patients: allergic rhinitis is not a trivial disease, Current Opinion in Allergy and Clinical Immunology, vol.8, issue.1, pp.1-9, 2008.
DOI : 10.1097/ACI.0b013e3282f3f42f

D. Leger, I. Annesi-maesano, F. Carat, M. Rugina, I. Chanal et al., Allergic Rhinitis and Its Consequences on Quality of Sleep, Archives of Internal Medicine, vol.166, issue.16, pp.1744-1748, 2006.
DOI : 10.1001/archinte.166.16.1744
URL : https://hal.archives-ouvertes.fr/hal-00595810

G. Canonica, J. Bousquet, J. Mullol, G. Scadding, and J. Virchow, A survey of the burden of allergic rhinitis in Europe, Allergy, vol.46, issue.s85, pp.17-25, 2007.
DOI : 10.1016/S0091-6749(00)90177-5

H. Nolte, S. Nepper-christensen, and V. Backer, Unawareness and undertreatment of asthma and allergic rhinitis in a general population, Respiratory Medicine, vol.100, issue.2, pp.354-362, 2006.
DOI : 10.1016/j.rmed.2005.05.012

J. Bousquet, H. Schünemann, B. Samolinski, P. Demoly, C. Baena-cagnani et al., Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs, Journal of Allergy and Clinical Immunology, vol.130, issue.5, pp.1049-1062, 2012.
DOI : 10.1016/j.jaci.2012.07.053

P. Howarth, H. Malling, M. Molimard, and P. Devillier, Analysis of allergen immunotherapy studies shows increased clinical efficacy in highly symptomatic patients, Allergy, vol.104, issue.Suppl 86, pp.321-327, 2012.
DOI : 10.1111/j.1398-9995.2011.02759.x

S. Durham, A. Birk, and J. Andersen, Days with severe symptoms: an additional efficacy endpoint in immunotherapy trials, Allergy, vol.8, issue.suppl. 92, pp.120-123, 2011.
DOI : 10.1111/j.1398-9995.2010.02434.x

S. Radulovic, M. Calderon, D. Wilson, and S. Durham, Sublingual immunotherapy for allergic rhinitis, Cochrane Database Syst Rev, vol.60, issue.1, p.2893, 2010.
DOI : 10.1002/14651858.CD002893.pub2

M. Calderon, T. Casale, A. Togias, J. Bousquet, S. Durham et al., Allergen-specific immunotherapy for respiratory allergies: From meta-analysis to registration and beyond, Journal of Allergy and Clinical Immunology, vol.127, issue.1, pp.30-38, 2010.
DOI : 10.1016/j.jaci.2010.08.024

M. Calderon, R. Mosges, M. Hellmich, and P. Demoly, Towards evidence-based medicine in specific grass pollen immunotherapy, Allergy, vol.336, issue.Suppl 86, pp.420-434, 2010.
DOI : 10.1111/j.1398-9995.2009.02292.x

R. Dahl, A. Kapp, G. Colombo, J. De-monchy, S. Rak et al., Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis, Journal of Allergy and Clinical Immunology, vol.118, issue.2, pp.434-440, 2006.
DOI : 10.1016/j.jaci.2006.05.003

A. Didier, H. Malling, M. Worm, F. Horak, S. Jäger et al., Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5???grass pollen tablet for seasonal allergic rhinitis, Journal of Allergy and Clinical Immunology, vol.120, issue.6, pp.1338-1345, 2007.
DOI : 10.1016/j.jaci.2007.07.046

A. Frankland and A. R. , PROPHYLAXIS OF SUMMER HAY-FEVER AND ASTHMA, The Lancet, vol.263, issue.6821, pp.1055-1057, 1954.
DOI : 10.1016/S0140-6736(54)91620-7

F. Horak, P. Zieglmayer, R. Zieglmayer, P. Lemell, P. Devillier et al., Early onset of action of a 5-grass-pollen 300-IR sublingual Calderón et al, BMC Medicine Page, vol.4, issue.5

A. Eifan, M. Shamji, and S. Durham, Long-term clinical and immunological effects of allergen immunotherapy, Current Opinion in Allergy and Clinical Immunology, vol.11, issue.6, pp.586-593, 2011.
DOI : 10.1097/ACI.0b013e32834cb994

S. Durham, Sustained effects of grass pollen AIT, Allergy, vol.125, pp.50-52, 2011.
DOI : 10.1111/j.1398-9995.2011.02639.x

M. Calderon, L. Cox, T. Casale, P. Moingeon, and P. Demoly, Multiple-allergen and single-allergen immunotherapy strategies in polysensitized patients: Looking at the published evidence, Journal of Allergy and Clinical Immunology, vol.129, issue.4, pp.929-934, 2012.
DOI : 10.1016/j.jaci.2011.11.019

H. Malling, A. Montagut, M. Melac, G. Patriarca, P. Panzner et al., Efficacy and safety of 5-grass pollen sublingual immunotherapy tablets in patients with different clinical profiles of allergic rhinoconjunctivitis, Clinical & Experimental Allergy, vol.39, issue.3, pp.387-393, 2009.
DOI : 10.1111/j.1365-2222.2008.03152.x

H. Nelson, M. Blaiss, H. Nolte, S. Würtz, J. Andersen et al., Efficacy and safety of the SQ-standardized grass allergy immunotherapy tablet in mono- and polysensitized subjects, Allergy, vol.129, issue.2, pp.252-255, 2013.
DOI : 10.1111/all.12074

M. Calderon, F. Simons, H. Malling, R. Lockey, P. Moingeon et al., Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile, Allergy, vol.156, issue.Suppl 1, pp.302-311, 2012.
DOI : 10.1111/j.1398-9995.2011.02761.x

S. Nissen, H. Kjaer, A. Høst, J. Nielsen, and S. Halken, The natural course of sensitization and allergic diseases from childhood to adulthood, Pediatric Allergy and Immunology, vol.113, issue.Suppl 1, pp.549-555, 2013.
DOI : 10.1111/pai.12108

S. Illi, E. Von-mutius, S. Lau, B. Niggemann, C. Grüber et al., Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study, The Lancet, vol.368, issue.9537, pp.763-770, 2006.
DOI : 10.1016/S0140-6736(06)69286-6

H. Van-bever, B. Lee, and L. Shek, Viewpoint: the future of research in pediatric allergy: what should the focus be? Pediatr Allergy Immunol, pp.5-10, 2012.